Skip to preprint detailsSkip to PREreviews

PREreviews of Incidence of Symptoms Associated with Post-Acute Sequelae of SARS-CoV-2 infection in Non-Hospitalized Vaccinated Patients Receiving Nirmatrelvir-Ritonavir

2 PREreviews

  1. PREreview by Heera Lal

    Covid 19 presented a varied range of symptoms in different infected individuals. Effects range from nonsymptomatic to severe symptoms leading to even death of individuals. In this study, authors have shown the effect of NMV-r (antiviral drugs) on post-acute sequelae of SARS-CoV-2 (PASC) in …

    Read the PREreview by Heera Lal
  2. PREreview by Jaeyoung Oh

    The main question that this preprint seeks to answer is whether or not Nirmatrelvir plus ritonavir, used as a treatment for non-hospitalized vaccinated patients, was effective at preventing long COVID symptoms. Overall, the paper found that NMV-r was indeed associated with a reduction in symptoms …

    Read the PREreview by Jaeyoung Oh